Quick Dispatch:
Your fda shortage semaglutide injection products resolved feb 21 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your fda shortage semaglutide injection products resolved feb 21 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s ships.
Need Help?
Questions about fda shortage semaglutide injection products resolved feb 21 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for fda shortage semaglutide injection products resolved feb 21 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s in your area.
Ozempic and Wegovy are no longer in shortage, FDA says
21.41
FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls
25.55
Ozempic and Wegovy officially moved off FDA's drug shortage list
20.54
Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders
21.02
The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made
27.99
FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over
27.71
Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide
22.30
